Model
Edge
Moonlake Immunotherapeutics
0001920545
Filing Type
3
Filing Date
4/14/2022
Updated
4/15/22, 10:06 AM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership